Gatralimab
Gatralimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Gatralimab is under investigation in clinical trial NCT02389452 (Study of Safety and Efficacy of 6 Ml Synvisc-one (Hylan G-F 20) in Indian Patients With Symptomatic Osteoarthritis of Knee(s) After Initial and Repeat Treatment).
| Trade Name | Gatralimab |
| Generic | Gatralimab |
| Gatralimab Other Names | Gatralimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Gatralimab
